Our expertise extensively represent the fields of health economics, medicine and data sciences. Our experience has been gathered in different positions in the pharmaceutical industry, healthcare, research, and academic institutions. Our wide-ranging experience and diversified expertise constitute our absolute strengths in serving our customers in the pharmaceutical and health technology fields and the healthcare sector.
Learn more about our experts by reading their profiles below and do not hesitate to contact us!
Jaana established Medaffcon in 2009. Prior to that, she worked in expert and management positions in the pharmaceutical industry for almost ten years. Jaana has also worked as a hospital doctor and is a specialist in surgery. In 1999, she defended her doctoral thesis on health policy related to customer payments in healthcare.
Jaana’s most essential contribution to Medaffcon’s team is her wide-ranging experience and expertise. Jaana is particularly interested in the future development of the Finnish healthcare sector. In particular, the use of knowledge in decision-making and new opportunities brought by digitalization fascinates Jaana. “I am especially looking forward to how we can improve personalized treatment options in healthcare and systematically evaluate the effectiveness and cost-effectiveness of treatments”.
Jarmo joined Medaffcon as a partner and CEO in 2010, having previously worked in various expert and management positions in pharma companies for eight years. Jarmo has a degree in economics and before entering the pharmaceutical industry, he held an office at the Turku School of Economics and also worked as a research fellow at Turku University Hospital.
Jarmo has strong expertise in new health technology innovations and how the demands and expectations of authorities, markets and customers are matched. He also brings to Medaffcon extensive experience in health economics and its applications in research and commercialization, as well as a broad understanding of the ever-changing operating environment.
“From an access point of view, the Finnish health technology market is constantly becoming more demanding and therefore also more attractive from my point of view. On the other hand, increasing demands to demonstrate the effectiveness and cost-effectiveness of healthcare are broadening the scope and opportunities for Medaffcon to be involved in the development of healthcare as a whole”.
Tatu’s doctoral dissertation, defended in 1999, focused on gallstone disease and cholesterol metabolism. Since then, he has worked in the pharmaceutical industry in different therapeutic areas, mainly as a Scientific or Medical Advisor, aiming to produce medical added value of high quality, benefiting all interest groups. Tatu has worked in the pharmaceutical industry or its interface for almost 20 years, in expert positions related to clinical research, drug development and Medical Affairs. He has experience in both national and international clinical trials, working as a Medical Researcher as well as in designing studies and in drafting protocols.
Tatu joined Medaffcon as a Partner in 2010. His background enables effective analyses and solution processes of challenges in the field. Tatu is particularly interested in the development of drug preforms from early-stage studies towards the markets. His interest for the bases at a molecular level and signal transmission routes is stunning. Tatu enjoys teaching and can explain even complex issues in a simple and understandable manner.
Mariann joined Medaffcon’s team in 2016 after finishing her PhD. The transition to real world evidence (RWE) research was a natural continuum to her previous research career. Through RWE studies, she has had the privilege to gain a broad insight into working with different stakeholders within the healthcare field. The vast proportion of her days goes towards interacting with clients, planning and performing RWE studies, and supporting Medaffcon’s RWE team. Subjects that keep her work interesting are the vast variability of customers and projects, problem-solving, and interacting with people.
“The number of RWE studies has increased since stakeholders within the healthcare industry have an increasing demand for knowledge-based decision making tools that need to be fulfilled. The future, therefore, has an ever-increasing emphasis on RWE”.
Sr. Scientific Project Manager Medical Affairs Lead
Sr. Scientific Project Manager Medical Affairs Lead
M.Sc. (Food Science), MBA
Kristiina joined Medaffcon as a Business development manager in 2012. She started her career in a CRO, after which she worked in scientific advisor and line manager positions in two large pharmaceutical organizations, now reaching already 15 years in the business. Kristiina holds master’s degrees in both Nature Sciences and Business (Henley MBA).
At Medaffcon, nowadays as a Medical Affairs team lead, Kristiina leverages her long experience from various stakeholders in the business and her vast therapeutic area expertise in close collaboration with her team to the benefit of customer assignments. When asking what the best part of this work is, she refers to the fast change and the continuous strive for the better, for all of us, as health care service utilizers. ”Every year, I feel that never before have we been working on such vast and important topics and yet, next year the feeling is the same again”.
Iiro joined Medaffcon in March 2017 as a Biostatistician. For the preceding four years, he has worked as a research assistant in an academic study group, analyzing clinical and genetic patient data. Iiro holds a Master of Science degree in Technology in Bioinformation Technology.
Iiro’s strengths include his strong expertise in statistics and data-analysis, hands-on experience in working with sensitive patient data, and strong interdisciplinary communication skills with experts from various fields. In the field, he is particularly interested in the large data amounts made available with the revolution of technology and how the information received such data can potentially be utilized to draw concrete conclusions, both in order to understand the nature of diseases and to advance the goals of the pharmaceutical industry and patient treatment.
“Machine learning and AI-based solutions will have a major impact on the healthcare sector now and in the future. However, effectively utilizing the already collected and available health-data will have a higher importance in order to improve health-care”.
Sr. Health Economist Access & HE Lead
Sr. Health Economist Access & HE Lead
M.Sc. (Economics & Health Economics)
Tatu joined Medaffcon in the fall of 2016. Tatu holds two master’s degrees, majoring in Marketing and Health Economics. Before joining Medaffcon, he worked in the pharmaceutical industry at Boehringer Ingelheim as an Account Manager. At Medaffcon, Tatu works mainly with health technology assessments and is the access & health economics team lead. Through his educational and professional background, Tatu has a wide range of expertise in the pharmaceutical industry and understands the needs of each function.
Tatu’s strength is his comprehensive understanding of the pharmaceutical industry and healthcare environment. Tatu is particularly interested in the possibility to turn data into understandable information to support healthcare decision-making.
“I love the hype around the utilization of real-world effectiveness and cost-effectiveness data. Now we need steps to include the data as a systematic part of the decision-making process, which allows the optimal allocation of resources”.
Ritva joined Medaffcon’s team in March 2018. Before this, she had worked for almost six years at Farenta in corresponding tasks, providing pharmaceutical companies with strategic consultation and expert assistance related to Market Access functions. In addition, Ritva holds more than 20 years of experience in the pharmaceutical industry, where she has worked as a Market Access Manager at Sanofi (12 years), as a Regulatory Affairs Manager at Bayer and as a Researcher in Pharmaceutical Product Development at Orion.
In the pharmaceutical industry, Ritva is interested in Market Access issues particularly due to their diversity and societal impact. “Market Access is a great observational spot to view the development of new innovative medicinal treatment, aiming to improve patients’ treatment in its entirety. I consider it important to increase cooperation between different actors in the pharmaceutical industry and to find such new solution models that make effective treatment optimally available for patients without raising society’s costs unreasonably“.
Liisa joined Medaffcon in January 2020. She has over ten years of experience of working as a scientific advisor and research scientist for private and public sector organizations. Liisa holds a PhD in medical genetics, and she mentions that especially the therapeutic areas related neurology and psychiatry appeal to her.
Liisa’s strengths include strong expertise on medical sciences and research, as well as on creating evidence-based content, because she also has experience of being a science book author. Establishing cross-scientific collaboration, scientific exchange, and creating networks are one of her key work philosophies.
One of her main professional interests is the secondary use of health-related data to create real-world-evidence in order to improve and develop treatment practices. ”Due to the unique registries and data lakes available in Finland, in principle all the required data is already available or accumulating all the time, which makes it important to utilize this real-world-data to improve patient care and general well-being.”
Sanna joined Medaffcon’s team in November 2019. In her PhD, she studied the potential of high-intensity interval training (HIIT) in the prevention and management of type 2 diabetes. After defending her PhD in 2018, she worked as a post-doctoral researcher at the University of Turku. In addition, Sanna has experience working as an entrepreneur in the field of work-wellbeing. As a base-education, she has two master’s degrees (Biomedicine and Exercise Physiology).
Sanna’s strengths include strong expertise in science, diverse educational background, excellent management skills and above all, her positive nature. She is fascinated by the dynamics and endless innovative opportunities in the healthcare industry. “It is extremely interesting to see how individual treatment paths can be tailored in the future for example based on the genome or different biomarkers. In addition, new digital solutions in the prevention and management of different diseases will surely improve health and the daily lives of many individuals”.
Kai joined Medaffcon in September 2020 after five years of Post doctorate studies in Australia. In his PhD thesis, Kai studied the role of lipoprotein receptors in neuronal cell death and continued his studies on deciphering the mechanisms and testing potential therapeutics for neurodegenerative diseases at the University of Melbourne. Kai completed his university degrees at the University of Helsinki and the Neuroscience Center, which included one semester exchange at the Victoria University of Wellington, New Zealand.
Due to his international educational background, Kai’s strengths include his adept ability to work in multicultural settings andcross disciplinaryprojects. Kai is fascinated by out-of-the-box scientific projects and how they emerge to challenge existing norms. “Data driven decision making, critical but constructive discussion and multifaceted cooperation can ensure a functional and healthy society in the face of future challenges. Together we are stronger and wiser.”
Kristiina joined Medaffcon’s RWE team in the fall of 2019. She holds a PhD and her doctoral dissertation concentrated on cell biology of a rare neurological disease. After defending her PhD, Kristiina worked on projects using iPS cell technology in several different research groups for rare diseases. In addition, she has experience in the most common diseases, as she has worked with diabetic research, for example.
“In this work, we can see from the field how know-how is effectively acquired and for what purposes it is used in healthcare. I look forward to seeing the full potential of biobank sample collections for future use in RWE research, including rare diseases”.
Bettina joined Medaffcon in February 2021. She has more than 15 years of experience of scientific work, in which the clinical applicability has always been in focus. Before joining Medaffcon, Bettina held the position of senior researcher at University of Helsinki. Bettina received her MSc degree from Åbo Akademi University during which she spent a year at University of Victoria, Canada. She received her PhD in tissue engineering from University of Tampere. As a result of a long career in science, Bettina also has a title of docent in Cell Biology.
Bettina has a strong background in cross disciplinary projects, working in multicultural teams and a solid interest in collaboration with health care professionals. Multidisciplinary projects where the knowledge of various experts is utilized for improved patient care are close to heart. In Medaffcon, Bettina is fueled by working with, sharing and applying scientific knowledge for advancing healthcare.
Riikka joined Medaffcon in February 2021. She has a wide-ranging experience from different therapy areas from atherosclerosis and birth asphyxia to neurodegeneration. She has more than 15 years of experience in research, three of which in Max Planck Institute in Germany. Her PhD thesis from 2011 focused on cholesterol metabolism.
Riikka’s strenghts include broad know-how and interest in diverse therapy areas, as well as enthusiasm and experience in both written and verbal scientific communication. At Medaffcon she enjoys varied projects and effectiveness of research.
Real world evidence fascinates Riikka because there is so much data, and more accumulating all the time, and most of this data is unused. There is potential for findings to support clinicians and the pharmaceutical industry, as well as alleviate the lives of patients. She is also happy that decisions in health care are increasingly evidence based.
Outi joined the Medaffcon team in February 2022. Outi has a master’s degree in Pharmacy, but for the most of her career she has been working as a clinical researcher in specialized care. Her previous research is from the field of clinical pharmacology. In 2020, Outi’s PhD on medication-related adverse events in specialized care was published at the University of Oulu. Among clinical research, Outi has gained experience also as a clinical pharmacist in specialized care.
The general knowledge of clinical pharmacology and the medication processes in health care are one of the strongest assets of Outi in RWE research. Outi is especially interested in rational medication and population-wide effectiveness studies on pharmacotherapies. Outi is also interested in AI methods and their use in improving the safety and efficacy of pharmacotherapies via personalized medication in the future. Outi considers her enthusiasm for pharmacology development as one of her best aspects.
Lasse joined Medaffcon in 2014 and holds currently a position of Sr Scientific Project Manager. Lasse has worked previously 14 years in the pharmaceutical industry in different positions having gained experience in sales, project management, and business development, and since 2009 in scientific expert functions in medical affairs being involved also in medical information, clinical research, quality assurance and pharmacovigilance activities. This has given Lasse a broad understanding of different areas and responsibilities in the pharmaceutical industry. He has completed a Master of Science degree in Pharmacy in 2003 (main subject pharmacology) and has been a Doctoral Student in a hemodynamics research group at the Faculty of Medicines in Tampere University since 2014. Lasse is interested in working with clinically relevant scientific information, and in particular in development of effectiveness assessment.
Krista joined Medaffcon in May 2017 as a Scientific Project Manager. Krista has worked in the pharmaceutical industry in both sales and scientific services. She has gained experience in pain management and diabetes therapeutic areas.
In the field, Krista is interested in constant development, changing lines of action and innovations. Moreover, she is interested in developing transparent and ethical cooperation between physicians and the pharmaceutical industry.
Krista holds a degree in Biomedicine and has gained extensive experience in working at the customer interface. Krista’s strengths include her solid presentation and human relations skills as well as her determination.
Tanja joined Medaffcon’s team in November 2016. Before that, she worked as a researcher at the National Institute for Health and Welfare. Tanja has also worked in an international research group, as a course instructor as well as in financial administration and customer service. She holds MSc degrees in both Health Economics and in the field of Economics and Business Administration.
Tanja’s strengths include her educational and occupational background in health economics from Finland and abroad. Tanja has a special interest in utilizing real-world evidence data to be used in evaluations. “By utilizing data resources to support decision-making we become more aware of how scarce resources should be allocated”.
Heini joined Medaffcon’s Market Access team in May 2018. She has graduated in Health Economics from the University of Eastern Finland, and her master’s thesis discusses risk-sharing agreements in the pharmaceutical market.
Heini is interested in the changes occurring in the pharmaceutical and healthcare industries as well as in the possibilities of Health Economics in assessing the methods and economic resources in the field. Heini’s assets include her state-of-the-art theoretical knowledge in the field of Health Economics, combined with practice- and patient-oriented thinking.
Jr. Health Economist
Jr. Health Economist
M.A. (Economics) ja M.Sc. (Health Economics)
Katerina joined Medaffcon in November 2020. She is internationally educated, holding two master’s degrees, a MA from the University of Aberdeen in Scotland and a MSc from the University of Rotterdam in the Netherlands, with a major in Economics and Health Economics, respectively.
Katerina brings to Medaffcon’s team strong theoretical expertise in health economics as well as an international perspective combined with patient and practice -oriented thinking.
She is particularly interested in the development of health economics methods and solutions at the international level, and their application in the local operating environment for the benefit of all stakeholders.
Kalle Snicker joined Medaffcon’s team in September 2017. He has a long history in the pharmaceutical industry. Over the years, he has gained experience in leading positions in sales and marketing, running the Baltic business unit, and in recent years, leading the oncology market access functions at Novartis Finland.
At Medaffcon, Kalle has been developing the introduction of hospital medicines, together with various pharmaceutical companies and authorities. In recent years, there has been a significant development in the introduction of hospital medicines, with the focus on the evaluation of medicines. The development and implementation of such evaluation are one of Kalle’s strongest competencies, which can benefit any actor in the industry.
Kalle’s strengths include his extensive and comprehensive view on how the industry functions as well as his ability to predict how future challenges can be considered and how the best possible result for the patient can be achieved in a new operational environment.
Emmi joined Medaffcon’s P&R team in December 2020. Previously Emmi worked at the University of Helsinki in different teaching positions while working on her doctoral dissertation. Emmi has wide-ranging experience from working at pharmacies and different pharmacy organizations. At Medaffcon Emmi hopes to immerse herself to the price and reimbursement processes and adapt to the ever-changing practices in the field. Market Access is interesting to Emmi because she has witnessed in her pharmacy work, the impact that access to new treatments has in the patients’ lives.
“It’s great to be able to help in bringing new treatments to the market and ensuring the best possible patient access to them. In these functions there’s always new things to learn and to get excited about.”
Salla joined Medaffcon’s P&R team in January 2022. She has extensive experience working in community pharmacy, with positions ranging from student to pharmacy manager. In addition, she has worked as an assistant in a research group studying rapid-acting antidepressants at the University of Helsinki. Salla has a master’s degree in pharmacy, majoring in pharmacology.
Salla has a strong understanding of pharmacology and an interest in diverse therapeutic areas, particularly in neurological and psychiatric disorders. As a market access specialist, she is motivated to use the latest scientific research to help patients access effective and reasonably priced treatments.
Samuli joined Medaffcon in November 2018. He acquired a master’s degree in Statistics at the University of Helsinki, specializing in Bioinformatics in September 2018. Before joining Medaffcon, Samuli had two years’ worth of experience in research as a research assistant at the University of Helsinki, where he contributed to unraveling the genetic and epigenetic background of psychological characteristics (Depsy-group).
Samuli is especially interested in producing influential research data based on information on real-world patients. He is also interested in applying varying statistical and machine learning methods. Samuli has a broad theoretical and methodological understanding, as well as experience in working with big data. He is a problem solver and has an analytical take on work.
“I see that the health sector is being transformed by digitalization. I am excited to further develop the new opportunities made possible by the automated collection of patient data”.
Johanna joined Medaffcon on February 2020 just after finishing her masters’ degree at Aalto University with major in bioinformatics and digital health. Previously, Johanna has been working as a research assistant both in brain imagining and in computational systems biology while reinforcing her knowledge in signal processing, analyses of genetic data, artificial neural networks, and development of new methods and tools to analyse genetic data. Johanna possesses strong knowledge in analysing genetic data thanks to broad know-how in life sciences but also in data and computational sciences. Johanna is a solution-oriented team worker, who does not fear to set goals high.
Johanna is interested in enhancing healthcare through bioinformatics and data sciences by combining both the medical and the computational know-how to cure diseases, improve healthcare and take step towards more personalised healthcare.
“I eagerly wait how the genome sequencing and gene testing revolutionise the medical field and boost more personalised treatments. Also, I believe that one day, we will have artificial intelligence as a standard tool for aiding doctors to diagnose and treat patients.”
Juhani joined Medaffcon in October 2020 as a data scientist. At Medaffcon Juhani conducts projects for the social and healthcare sector developing data driven decision-making in the field. Prior to joining Medaffcon, Juhani has worked as a data scientist in a global IT company as well as a scientist at the University of Turku in the Medical Bioinformatics Centre (MBC) and Functional Foods Forum (FFF). Juhani holds a Doctor of Science in Technology degree (2017) and the topic of his thesis was the development of human gut microbiota in early infancy.
Juhani has experience from applying statistical and machine learning methods in medicine and due to his multidisciplinary background, he can easily communicate with people with varied expertise ranging from clinicians to IT-professionals. “Knowledge management and business intelligence have become hot topics also in the social and healthcare sectors. It is very interesting to be involved in harnessing the vast amounts of data available in the systems to actual usable information to support decision making. Both traditional statistics as well as advanced analytics and artificial intelligence will be in a key role in this job.”
Saara started as a Data Scientist in Medaffcon’s analytics team in June 2021. Before Medaffcon, she has worked i.a. as a research assistant at Aalto University and as a data scientist at a large Finnish retail supply chain optimization software company. She is a Master of Science (tech.) in bioinformation technology from Aalto University.
Due to Saara’s multifaceted work background, she has a vast experience in the application statistical methods and machine learning both in academic research and product development. She is excited about the possibilities that the recent developments in data handling technologies bring to genetic analysis and personalized medicine. “Being able to utilize the vast amounts of real-world patient data enables for taking a more comprehensive outlook on healthcare as well as the development of new treatments. Hopefully, it will also revolutionize the prevention of various diseases.“
Jr. Data Scientist
Jr. Data Scientist
B.Sc. (Tech.), M.Sc. (Tech.) Student
Olivia joined Medaffcon in 2021 as a trainee to work on her Master’s thesis. She is finishing her studies in bioinformatics and digital health at Aalto University and has also worked as teaching assistant alongside her studies there for three years. Her main strengths are analytical thinking, problem solving skills and proactive mindset.
She is interested in data analysis in the field of social and healthcare to support decision making in improving social and healthcare services and allocating their resources more effectively.
Anna joined Medaffcon’s analytics team in the fall of 2021. She has a master’s degree in Bioinformation Technology from Aalto University, and her studies focused primarily on mathematical modeling and machine learning. She has worked at Aalto University’s Department of Neuroscience and Biomedical Engineering as a research assistant, as a teacher in a mathematical modeling course, and in the last years before Medaffcon as a data scientist in a startup developing a medical device.
Anna has a strong background in the application of statistics and especially machine learning methods to various datasets. Anna also has experience in conducting research, all the way from collecting data to analyzing the results and scientific writing. She is particularly interested in solving real-world problems faced by healthcare and medicine using mathematical modeling methods and artificial intelligence.
“The constantly increasing amount of health data, combined with the modern computational capacity and evolving modeling methods, create enormous potential for findings that could hardly be detected by purely manual examination.”
Tomi Vahevaara started working at Medaffcon in January 2017 as a Sales Director. He has been working in the pharmaceutical industry for over 35 years. Therefore, he has gained wide-ranging experience in international expert and managerial positions within the innovative pharmaceutical industry. Before joining Medaffcon, Tomi worked for ten years as the Managing Director of Eli Lilly for Finland, the Baltic States, and Poland.
Tomi has solid and wide-ranging expertise in different positions in the pharmaceutical field and is well connected in the entire health industry network. He serves as the Chairman of the Board of the Finnish Mutual Insurance Company for Pharmaceutical Injury Indemnities and as a Board Member in the Finnish Co-operative for Pharmaceutical Injury Indemnities. Tomi is particularly interested in the significant economic and investment opportunities for Finland and those companies working in the Finnish health industry.
Tuuli joined Medaffcon in May 2012 as an Assistant. She completed her Bachelor of Business Administration (International Business) degree in May 2015, after drafting her Bachelor’s Thesis for Medaffcon on the internationalisation practices of expert organisations. After graduation, Tuuli’s job description at Medaffcon has included, inter alia, financial administration and marketing tasks.
Since December 2015, Tuuli has worked as Marketing Lead, managing Medaffcon’s 2 websites and social media presence, designing and implementing marketing activities and online content, and organizing Medaffcon’s events.
Marissa Vahevaara joined Medaffcon in March 2021 as a trainee and works as a sales support and assists in administrative tasks. She is studying business administration at Haaga-Helia with a focus on marketing and communications.
Marissa has always been interested in the well-being and health industry, as she feels her work has a tangible impact on the well-being of people and offers continuous learning opportunities. At Medaffcon, Marissa thinks that seeing the latest industry trends and requirements is especially attractive.